Stromal cells and osteoclasts are responsible for exacerbated collagen-induced arthritis in interferon-β-deficient mice

Arthritis and Rheumatism

Volumn 52, Issue 12, 2005, Pages 3739-3748

  Treschow, Alexandra P ^a   Teige, Ingrid ^a   Nandakumar, Kutty S ^a   Holmdahl, Rikard ^a   Issazadeh Navikas, Shohreh ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CD11B ANTIGEN; COLLAGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL COUNT; CELL INFILTRATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLOW CYTOMETRY; HISTOLOGY; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; MACROPHAGE; MALE; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; STROMA CELL; SYNOVIOCYTE; T LYMPHOCYTE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CHRONIC DISEASE; COLLAGEN TYPE II; FIBROBLASTS; INTERFERON-BETA; MACROPHAGES; MICE; MICE, MUTANT STRAINS; OSTEOCLASTS; STROMAL CELLS; SYNOVIAL MEMBRANE; T-LYMPHOCYTES;

EID: 29144459002     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21496     Document Type: Article

References (45)

1. Uze G, Lutfalla G, Gresser I. Genetic transfer of a functional human Interferon α receptor into mouse cells: cloning and expression of its cDNA. Cell 1990;60:225-34.
2. Novick D, Cohen B, Rubinstein M. The human interferon α/β receptor: characterization and molecular cloning. Cell 1994;77:391-400.
3. Van den Broek MF, Muller U, Huang S, Zinkernagel RM, Aguet M. Immune defence in mice lacking type I and/or type II interferon receptors. Immunol Rev 1995;148:5-18.
4. Shen H, Zhang M, Minuk GY, Gong Y. Different effects of rat interferon α, β and γ on rat hepatic stellate cell proliferation and activation. BMC Cell Biol 2002;3:9-17.
5. Deonarain R, Alcami A, Alexiou M, Dallman MJ, Gewert DR, Porter AC. Impaired antiviral response and α/β interferon induction in mice lacking β interferon. J Virol 2000;74:3404-9.
6. Erlandsson L, Blumenthal R, Eloranta ML, Engel H, Alm G, Weiss S, et al. Interferon-β is required for interferon-α production in mouse fibroblasts. Curr Biol 1998;8:223-6.
7. Buckley CD. Michael Mason prize essay 2003: why do leucocytes accumulate within chronically inflamed joints? Rheumatology (Oxford) 2003;42:1433-44.
8. Deonarain R, Verma A, Porter AC, Gewert DR, Platanias LC, Fish EN. Critical roles for IFN-β in lymphoid development, myelopoiesis, and tumor development: links to tumor necrosis factor α. Proc Natl Acad Sci U S A 2003;100:13453-8.
9. Takayanagi H, Kim S, Taniguchi T. Signaling crosstalk between RANKL and interferons in osteoclast differentiation. Arthritis Res 2002;4 Suppl 3:S227-32.
10. Wang K, Scheel-Toellner D, Wong SH, Craddock R, Caamano J, Akbar AN, et al. Inhibition of neutrophil apoptosis by type I IFN depends on cross-talk between phosphoinositol 3-kinase, protein kinase C-delta. and NF-κB signaling pathways. J Immunol 2003;171:1035-41.
11. Jungo F, Dayer JM, Modoux C, Hyka N, Burger D. IFN-β inhibits the ability of T lymphocytes to induce TNF-α and IL-1β production in monocytes upon direct cell-cell contact. Cytokine 2001;14:272-82.
12. Rep MH, Hintzen RQ, Polman CH, van Lier RA. Recombinant interferon-β blocks proliferation but enhances interleukin-10 secretion by activated human T-cells. J Neuroimmunol 1996;67:111-8.
13. Van Holten J, Reedquist K, Sattonet-Roche P, Smeets TJ, Plater-Zyberk C, Vervoordeldonk MJ, et al. Treatment with recombinant interferon-β reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis. Arthritis Res Ther 2004;6:R239-49.
14. Abdul-Ahad AK, Galazka AR, Revel M, Biffoni M, Borden EC. Incidence of antibodies to interferon-β in patients treated with recombinant human interferon-β 1a from mammalian cells. Cytokines Cell Mol Ther 1997;3:27-32.
15. Tak PP, Hart BA, Kraan MC, Jonker M, Smeets TJ, Breedveld FC. The effects of interferon β treatment on arthritis. Rheumatology (Oxford) 1999;38:362-9.
16. Triantaphyllopoulos KA, Williams RO, Tailor H, Chernajovsky Y. Amelioration of collagen-induced arthritis and suppression of interferon-γ, interleukin-12, and tumor necrosis factor α production by interferon-β gene therapy. Arthritis Rheum 1999;42:90-9.
17. Van Holten J, Plater-Zyberk C, Tak PP. Interferon-β for treatment of rheumatoid arthritis? Arthritis Res 2002;4:346-52.
18. Smeets TJ, Dayer JM, Kraan MC, Versendaal J, Chicheportiche R, Breedveld FC, et al. The effects of interferon-β treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis. Arthritis Rheum 2000;43:270-4.
19. Holten JV, Smeets TJ, Blankert P, Tak PP. Expression of interferon β (IFN-β) in synovial tissue from rheumatoid arthritis patients compared to osteoarthritis and reactive arthritis patients. Ann Rheum Dis 2005. E-pub ahead of print.
20. Tak PP. IFN-β in rheumatoid arthritis. Front Biosci 2004;9:3242-7.
21. Van Holten J, Pavelka K, Vencovsky J, Stahl H, Rozman B, Genovese M, et al. A multicentre, randomised, double-blind, placebo controlled phase II study of subcutaneously administered interferon β1a in the treatment of patients with active rheumatoid arthritis. Ann Rheum Dis 2004;64:64-9.
22. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980;283:666-8.
23. Corthay A, Johansson A, Vestberg M, Holmdahl R. Collagen-induced arthritis development requires α β T cells but not γ delta T cells: studies with T cell-deficient (TCR mutant) mice. Int Immunol 1999;11:1065-73.
24. Mo JA, Holmdahl R. The B cell response to autologous type II collagen: biased V gene repertoire with V gene sharing and epitope shift. J Immunol 1996;157:2440-8.
25. Teige I, Treschow A, Teige A, Mattsson R, Navikas V, Leanderson T, et al. IFN-β gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J Immunol 2003;170:4776-84.
26. Miller EJ. Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin. Biochemistry 1972;11:4903-9.
27. Michaelsson E, Andersson M, Engstrom A, Holmdahl R. Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection. Eur J Immunol 1992;22:1819-25.
28. Holmdahl R, Carlsen S, Mikulowska A, Vestberg M, Brunsberg U, Hansson A, et al. Genetic analysis of mouse models for rheumatoid arthritis. In: Adolph KW, editor. Human genome methods. New York: CRC Press; 1998. p. 215-38.
29. Holmdahl R, Klareskog L, Andersson M, Hansen C. High antibody response to autologous type II collagen is restricted to H-2q. Immunogenetics 1986;24:84-9.
30. Nandakumar KS, Svensson L, Holmdahl R. Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol 2003;163:1827-37.
31. Svensson L, Jirholt J, Holmdahl R, Jansson L. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 1998;111:521-6.
32. Malmstrom V, Michaelsson E, Burkhardt H, Mattsson R, Vuorio E, Holmdahl R. Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc Natl Acad Sci U S A 1996;93:4480-5.
33. Noronha A, Toscas A, Jensen MA. Interferon β decreases T cell activation and interferon γ production in multiple sclerosis. J Neuroimmunol 1993;46:145-53.
34. Nandakumar KS, Backlund J, Vestberg M, Holmdahl R. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells. Arthritis Res Ther 2004;6:R544-50.
35. Giovannoni G, Miller DH. Multiple sclerosis and its treatment. J R Coll Physicians Lond 1999;33:315-22.
36. Matheu V, Treschow A, Navikas V, Issazadeh-Navikas S. Upregulation of B7 molecules (CD80 and CD86) and exacerbated eosinophilic pulmonary inflammatory response in mice lacking the IFN-β gene. J Allergy Clin Immunol 2003;111:550-7.
37. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 2000;408:600-5.
38. Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999;10:451-61.
39. Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis? [editorial]. Arthritis Rheum 1990;33:768-73.
40. Fox DA. The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives [review]. Arthritis Rheum 1997;40:598-609.
41. Kazkaz H, Isenberg D. Anti B cell therapy (rituximab) in the treatment of autoimmune diseases. Curr Opin Pharmacol 2004;4:398-402.
42. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J Exp Med 2004;200:277-85.
43. Suzuki M, Uetsuka K, Shinozuka J, Nakayama H, Doi K. Immunohistochemical study on type II collagen-induced arthritis in DBA/1J mice. Exp Anim 1997;46:259-67.
44. Ritchlin C. Fibroblast biology: effector signals released by the synovial fibroblast in arthritis. Arthritis Res 2000;2:356-60.
45. Taylor PC, Peters AM, Paleolog E, Chapman PT, Elliott MJ, McCloskey R, et al. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor a blockade in patients with rheumatoid arthritis. Arthritis Rheum 2000;43:38-47.